SPYRE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.95 USD | +2.64% |
|
+5.97% | +62.41% |
| May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
| May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
|---|---|---|---|---|
| Last | 33.09 $ | 32.06 $ | 34.05 $ | 34.95 $ |
| Volume | 295 562 | 261 996 | 231 487 | 393 781 |
| Change | +0.33% | -3.11% | +6.21% | +2.64% |
| Opening | 33.53 | 32.62 | 32.28 | 34.45 |
| High | 33.87 | 33.72 | 34.34 | 35.83 |
| Low | 31.76 | 31.83 | 32.07 | 34.13 |
Performance
| 1 day | +2.64% | ||
| 1 week | +5.97% | ||
| 1 month | +5.81% | ||
| 3 months | +27.37% | ||
| 6 months | +87.30% | ||
| Current year | +62.41% | ||
| 1 year | +976.21% | ||
| 3 years | -78.85% | ||
| 5 years | -77.60% |
Volumes
marketsDaily volume
393 781
Estimated daily volume
393 781
Avg. Volume 20 sessions
309 053
Daily volume ratio
1.27
Avg. Volume 20 sessions USD
10 801 402.35
Record volume 1
10 228 381
Record volume 2
3 156 959
Record volume 3
2 233 298
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 774 844 320
Net sales (USD)
886 000
Number of employees
30
Sales / Employee (USD)
29 533
Free-Float
70.36 %
Free-Float capitalization (USD)
1 574 158 338
Average Daily Capital Traded
0.61%
Highs and lows
1 week
31.76
35.83
1 month
31.7640.49
Current year
18.5447.97
1 year
2.6647.97
3 years
2.66212.50
5 years
2.66284.50
10 years
2.66318.75
Indicators
Moving average 5 days
33.42
Moving average 20 days
35.48
Moving average 50 days
35.89
Moving average 100 days
32.13
Price spread / (MMA5)
-4.38%
Price spread / (MMA20)
+1.53%
Price spread / (MMA50)
+2.68%
Price spread / (MMA100)
-8.07%
STIM
RSI 9 days
45.74
RSI 14 days
46.59
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.64% | +5.97% | +62.41% | +976.21% | 1.77B | ||
| +2.77% | -0.35% | +11.91% | +40.72% | 118B | ||
| +1.06% | -0.49% | +11.60% | +33.25% | 106B | ||
| +1.87% | +3.76% | -4.68% | -4.26% | 24.28B | ||
| +1.04% | +0.89% | -0.82% | -6.56% | 21.96B | ||
| +0.31% | +0.55% | -10.12% | -28.92% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -35.22% | 16.37B | ||
| -3.50% | -2.53% | -17.47% | -32.63% | 15.56B | ||
| -0.91% | -2.86% | +2.77% | +51.25% | 13.63B | ||
| +4.28% | +5.12% | +34.58% | +5.00% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +189.28% | 8.87B | ||
| -7.66% | -3.38% | -33.51% | -37.65% | 7.29B | ||
| -1.71% | +3.60% | +7.26% | +55.34% | 7.75B | ||
| -20.47% | +156.95% | +232.76% | +432.82% | 6.1B | ||
| +0.09% | +2.20% | +11.89% | +41.90% | 7.65B | ||
| +0.25% | -1.43% | -3.92% | +24.97% | 7.42B | ||
| Average | -1.43% | +19.84% | +21.26% | +106.60% | ||
| Weighted average by Cap. | +0.73% | +5.89% | +9.95% | +35.47% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
8d1234a412bbc8bb3.sPaZWuq5ax32xnrPLGFFy9mNYVk1rymJmMV_t3G8N6Y.5bTPM4buXkrD9gy_RSscrb7-FwZtzk-xqYYT4yf5YOuCsekWm9wJTaWBHQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 34.95 | 131,646 | 256,245 |
| 03:59:59 pm | 34.95 | 128 | 124,599 |
| 03:59:58 pm | 34.99 | 100 | 124,471 |
| 03:59:58 pm | 34.99 | 100 | 124,371 |
| 03:59:44 pm | 34.99 | 100 | 124,271 |
| 03:59:42 pm | 34.98 | 100 | 124,171 |
| 03:59:42 pm | 34.93 | 100 | 124,071 |
| 03:59:42 pm | 34.93 | 147 | 123,971 |
| 03:59:41 pm | 34.95 | 200 | 123,824 |
| 03:59:37 pm | 34.98 | 100 | 123,624 |
Monthly variations
Annual change
| 2024 | +62.41% | ||
| 2023 | +91.33% | ||
| 2022 | -90.53% | ||
| 2021 | -39.64% | ||
| 2020 | +3.01% | ||
| 2019 | +2.00% | ||
| 2018 | +38.45% | ||
| 2017 | +24.37% | ||
| 2016 | -63.72% |
- Stock Market
- Equities
- SYRE Stock
- Quotes Spyre Therapeutics, Inc.
